This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 1994-1996.
Company Filing History:
Years Active: 1994-1996
Title: Lyman E. Davis: Innovator in Immunoassays and Cancer Detection
Introduction
Lyman E. Davis is a notable inventor based in Chicago, IL, recognized for his contributions to the field of immunoassays and cancer detection. With a total of 2 patents, his work has significantly advanced the methodologies used in medical diagnostics.
Latest Patents
Davis's latest patents include an innovative immunoassay for glycosylated proteins. This immunoassay focuses on proteins that are non-enzymatically glycosylated on the alpha amino group of their N-terminal amino acid. The process involves providing a sample containing the glycosylated protein, reacting it with a reducing agent, and then contacting the reduced glycosylated protein with a specific antibody. This method allows for the detection and quantification of the glycosylated protein bound to the antibody. Additionally, he has developed a method for detecting gastrointestinal cancer in mammals. This method includes measuring the amount of antibody to a specific antigen in a body fluid, which can indicate the presence of cancer.
Career Highlights
Lyman E. Davis is affiliated with Northwestern University, where he continues to contribute to research and innovation in his field. His work has not only led to advancements in immunoassays but also in cancer screening methodologies.
Collaborations
Davis collaborates with Byron E. Anderson, enhancing the research output and innovation potential within their projects.
Conclusion
Lyman E. Davis's contributions to immunoassays and cancer detection exemplify the impact of innovative research in medical diagnostics. His patents reflect a commitment to improving health outcomes through scientific advancement.